However, a negative point is that there are no third-party quality assurance and testing reports
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
if anything, tolerability concerns argue for going slower
The route of administration for gut indications differs from musculoskeletal use
They're right. He said, What you don't know is that I've been on a diet for six months and I've lost 45 pounds. The reason he's nicknamed Big Ed is that he was 265 pounds when I met him
Individuals with certain genetic variants may be more susceptible to environmental factors such as stress, infections, or iodine exposure, which can initiate or exacerbate the autoimmune process